Cargando…

Erratum to "Efficacy and Safety of Weekly Alendronate Plus Vitamin D(3) 5600 IU versus Weekly Alendronate Alone in Korean Osteoporotic Women: 16-Week Randomized Trial" by Kim KJ, et al. (Yonsei Med J 2014;55:715-24.)

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Yonsei University College of Medicine 2014
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4075384/ http://dx.doi.org/10.3349/ymj.2014.55.4.1163

Ejemplares similares

Efficacy and Safety of Weekly Alendronate Plus Vitamin D(3) 5600 IU versus Weekly Alendronate Alone in Korean Osteoporotic Women: 16-Week Randomized Trial
por: Kim, Kwang Joon, et al.
Publicado: (2014)

Weekly oral alendronate in mevalonate kinase deficiency
por: Cantarini, Luca, et al.
Publicado: (2013)

Retraction: Hydrogen Peroxide as an Effective Disinfectant for Pasteurella multocida. Yonsei Med J 2014;55:1152-6
por: Jung, In-Soo, et al.
Publicado: (2016)

Cost-effectiveness of sequential daily teriparatide/weekly alendronate compared with alendronate monotherapy for older osteoporotic women with prior vertebral fracture in Japan
por: Mori, Takahiro, et al.
Publicado: (2021)

Treatment with once‐weekly alendronate oral jelly compared with once‐weekly alendronate oral tablet for Japanese patients with primary osteoporosis: An open‐label, prospective, observational study
por: Okimoto, Nobukazu, et al.
Publicado: (2018)

Sequential therapy with once-weekly teriparatide injection followed by alendronate versus monotherapy with alendronate alone in patients at high risk of osteoporotic fracture: final results of the Japanese Osteoporosis Intervention Trial-05
por: Mori, Satoshi, et al.
Publicado: (2022)

LATE ONSET CALCIFICATION FOLLOWING JUVENILE DERMATOMYOSITIS: RESPONSE WITH WEEKLY ALENDRONATE
por: Kaliyadan, Feroze, et al.
Publicado: (2011)

Erratum to "Diagnostic Role of Conventional Ultrasonography and Shearwave Elastography in Asymptomatic Patients with Diffuse Thyroid Disease: Initial Experience with 57 Patients" by Kim I, et al. (Yonsei Med J 2014;55:247-53.)
Publicado: (2014)

SAT-LB092 Adherence to Weekly Alendronate Predicts Mortality in Male US Military Veterans
por: Puri, Ritika, et al.
Publicado: (2019)

Predictors and Outcomes Associated With Adherence to Weekly Alendronate in US Military Veterans: Clinical Research Study
por: Bou Malham, Sarah, et al.
Publicado: (2019)

Erratum to “Diagnostic Algorithm to Reflect Regressive Changes of Human Papilloma Virus in Tissue Biopsies” by Lhee MJ, et al. (Yonsei Med J 2014;55:331-338.)
Publicado: (2017)

Cost–effectiveness of weekly gastro-resistant risedronate 35 mg, compared with weekly alendronate 70 mg tablets, in the treatment of postmenopausal osteoporosis in Spain
por: Casado, Enrique, et al.
Publicado: (2023)

First Indian prospective randomized comparative study evaluating adherence and compliance of postmenopausal osteoporotic patients for daily alendronate, weekly risedronate and monthly ibandronate regimens of bisphosphonates
por: Tandon, Vishal R., et al.
Publicado: (2014)

Cost‐Effectiveness of Sequential Teriparatide/Alendronate Versus Alendronate‐Alone Strategies in High‐Risk Osteoporotic Women in the US: Analyzing the Impact of Generic/Biosimilar Teriparatide
por: Mori, Takahiro, et al.
Publicado: (2019)

Erratum to "Histogram Analysis of Hepatobiliary Phase MR Imaging as a Quantitative Value for Liver Cirrhosis: Preliminary Observations" by Choi JY, et al. (Yonsei Med J 2014;55:651-9.)
Publicado: (2014)

Erratum to "Agmatine Improves Cognitive Dysfunction and Prevents Cell Death in a Streptozotocin-Induced Alzheimer Rat Model" by Song J, et al. (Yonsei Med J 2014;55:689-99.)
Publicado: (2015)

Nickel alendronate
por: Sikorska, Małgorzata, et al.
Publicado: (2012)

Endoscopic comparison of alendronate alone and the enteric-coated alendronate with calcitriol combination in postmenopausal Korean females
por: Mok, Ji Oh, et al.
Publicado: (2013)

Treatment persistence with once-monthly ibandronate and patient support vs. once-weekly alendronate: results from the PERSIST study*
por: COOPER, A, et al.
Publicado: (2006)

Erratum to "LRIG1 Enhances Chemosensitivity by Modulating BCL-2 Expression and Receptor Tyrosine Kinase Signaling in Glioma Cells" by Guo Z, et al. (Yonsei Med J 2014;55:1196-205.)
Publicado: (2014)

A randomized, controlled trial of once-weekly teriparatide injection versus alendronate in patients at high risk of osteoporotic fracture: primary results of the Japanese Osteoporosis Intervention Trial-05
por: Hagino, H., et al.
Publicado: (2021)

Comparison of the Effects of Denosumab and Alendronate on Cardiovascular and Renal Outcomes in Osteoporotic Patients
por: Hsu, Tsuen-Wei, et al.
Publicado: (2019)

Once-weekly oral medication with alendronate does not prevent migration of knee prostheses: A double-blind randomized RSA study
por: Hansson, Ulrik, et al.
Publicado: (2009)

A comparative study of zoledronic acid and once weekly Alendronate in the management of acute Charcot arthropathy of foot in patients with diabetes mellitus
por: Bharath, R., et al.
Publicado: (2013)

Erratum to "Effect of 6% Hydroxyethyl Starch 130/0.4 as a Priming Solution on Coagulation and Inflammation Following Complex Heart Surgery" by Cho JE, et al. (Yonsei Med J 2014;55:625-34.)
Publicado: (2014)

The influence of alendronate and tooth extraction on the incidence of osteonecrosis of the jaw among osteoporotic subjects
por: Chiu, Wei-Yih, et al.
Publicado: (2018)

Alendronate release from calcium phosphate cement for bone regeneration in osteoporotic conditions
por: van Houdt, Claire I. A., et al.
Publicado: (2018)

The Gradual Release of Alendronate for the Treatment of Critical Bone Defects in Osteoporotic and Control Rats
por: Hedvičáková, Věra, et al.
Publicado: (2023)

Effects of genistein aglycone in osteoporotic, ovariectomized rats: a comparison with alendronate, raloxifene and oestradiol
por: Bitto, A, et al.
Publicado: (2008)

The role of counselling and other factors in compliance of postmenopausal osteoporotic patients to alendronate 70 therapy
por: Sewerynek, Ewa, et al.
Publicado: (2013)

Alendronate slows down aortic stenosis progression in osteoporotic patients: An observational prospective study
por: Alishiri, Gholamhossein, et al.
Publicado: (2020)

Cost-Effectiveness of Zoledronic Acid Versus Oral Alendronate for Postmenopausal Osteoporotic Women in China
por: You, Ruxu, et al.
Publicado: (2020)

Impact of Alendronate Sodium plus Elcatonin on Postoperative Bone Pain in Patients with Osteoporotic Fractures
por: Wang, Baohui, et al.
Publicado: (2022)

Alendronate Sodium in the Management of Osteoporosis
por: Prinsloo, P J J, et al.
Publicado: (2006)

Short term sodium alendronate administration improves the peri-implant bone quality in osteoporotic animals
por: de OLIVEIRA, Danila, et al.
Publicado: (2017)

Comparison of Risk of Osteoporotic Fracture in Denosumab vs Alendronate Treatment Within 3 Years of Initiation
por: Pedersen, Alma B., et al.
Publicado: (2019)

Cost-effectiveness of zoledronic acid compared with sequential denosumab/alendronate for older osteoporotic women in Japan
por: Mori, Takahiro, et al.
Publicado: (2021)

Effects of alendronate sodium combined with InterTan on osteoporotic femoral intertrochanteric fractures and fracture recurrence
por: Wang, Ke-Meng, et al.
Publicado: (2022)

Retraction: Paper “Comparison of Effect of Treatment with Etidronate and Alendronate on Lumbar Bone Mineral Density in Elderly Women with Osteoporosis” by Iwamoto J, et al. [Yonsei Med J 2005;46(6):750-758]
Publicado: (2019)

Nikon D5600 for dummies
por: King, Julie Adair
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_iccm4ho62lbiprfgm61k5phttc